+

PE20070075A1 - Procedimiento de preparacion para compuestos inhibidores de renina - Google Patents

Procedimiento de preparacion para compuestos inhibidores de renina

Info

Publication number
PE20070075A1
PE20070075A1 PE2006000621A PE2006000621A PE20070075A1 PE 20070075 A1 PE20070075 A1 PE 20070075A1 PE 2006000621 A PE2006000621 A PE 2006000621A PE 2006000621 A PE2006000621 A PE 2006000621A PE 20070075 A1 PE20070075 A1 PE 20070075A1
Authority
PE
Peru
Prior art keywords
group
formula
procedure
preparation
preparation procedure
Prior art date
Application number
PE2006000621A
Other languages
English (en)
Inventor
Stuart John Mickel
Sedelmeier Gottfried
Frank Schafer
Michael Foulkes
Hans Hirt
Walter Prikoszovich
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20070075A1 publication Critical patent/PE20070075A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

REFERIDA A UN PROCEDIMIENTO PARA LA PREPARACION DE UN COMPUESTO DE FORMULA III, QUE CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (I) CON UN RESIDUO CAPAZ DE TRANSFORMAR EL HIDROXI EN LA FORMULA 1 A X, EN DONDE R ES H, ALQUILO, ALCOXIALQUILO; R1 ES H, ALQUILO O ALCOXIALQUILO; R2 ES H O UN GRUPO HIDROXILO-PROTECTOR; R3 ES H, ALQUILO SUSTITUIDO O NO NO SUSTITUIDO; PG ES UN GRUPO AMINO-PROTECTOR TAL COMO TER-BUTOXICARBONILO, BENCILOXICARBONILO, ENTRE OTROS; X ES UN GRUPO DISTINTO A HIDROXI O H, PARTICULARMENTE ES UN GRUPO SALIENTE SELECCIONADO DE ACIDO HIDROHALICO, UN HALOGENURO DE TIONILO, PX*3, POX*3, PX*5, UNA COMBINACION DE TRIFENILFOSFINA Y HALOGENO Y UN DERIVADO ACTIVO DE UN ACIDO SULFONICO ORGANICO; X* ES UN HALOGENURO. DICHO PROCEDIMIENTO ES UTIL EN LA PREPARACION DE COMPUESTOS INHIBIDORES DE RENINA TAL COMO ALISCIREN.
PE2006000621A 2005-06-08 2006-06-06 Procedimiento de preparacion para compuestos inhibidores de renina PE20070075A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0511686.8A GB0511686D0 (en) 2005-06-08 2005-06-08 Organic compounds

Publications (1)

Publication Number Publication Date
PE20070075A1 true PE20070075A1 (es) 2007-03-16

Family

ID=34835327

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2006000621A PE20070075A1 (es) 2005-06-08 2006-06-06 Procedimiento de preparacion para compuestos inhibidores de renina
PE2009000932A PE20091359A1 (es) 2005-06-08 2006-06-06 Proceso de preparacion de compuestos organicos intermediarios de inhibidores de renina

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2009000932A PE20091359A1 (es) 2005-06-08 2006-06-06 Proceso de preparacion de compuestos organicos intermediarios de inhibidores de renina

Country Status (24)

Country Link
US (2) US7767831B2 (es)
EP (2) EP1896411A2 (es)
JP (2) JP2008542415A (es)
KR (1) KR20080014011A (es)
CN (1) CN101193860B (es)
AR (1) AR054374A1 (es)
AU (1) AU2006256938B2 (es)
BR (1) BRPI0611919A2 (es)
CA (1) CA2608575A1 (es)
EC (1) ECSP077986A (es)
GB (1) GB0511686D0 (es)
GT (1) GT200600208A (es)
IL (1) IL187004A0 (es)
MA (1) MA29563B1 (es)
MX (1) MX2007015418A (es)
NO (1) NO20080080L (es)
NZ (2) NZ591010A (es)
PE (2) PE20070075A1 (es)
RU (1) RU2418785C2 (es)
SG (1) SG155209A1 (es)
TN (1) TNSN07465A1 (es)
TW (1) TW200716544A (es)
WO (1) WO2006131304A2 (es)
ZA (1) ZA200709076B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0521083D0 (en) 2005-10-17 2005-11-23 Novartis Ag Organic compounds
DE102007049039A1 (de) 2007-10-11 2009-04-16 Reuter Chemischer Apparatebau Kg Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung
EP2062874B1 (en) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Process and intermediates for the preparation of aliskiren
PT2225200E (pt) * 2007-12-24 2014-01-21 Dsm Ip Assets Bv Síntese convergente de inibidores da renina e intermediários úteis nesta
EP2189442B1 (en) 2008-11-20 2014-10-01 Krka Tovarna Zdravil, D.D., Novo Mesto Process and intermediates for the preparation of aliskiren
IN2012DN00862A (es) * 2009-08-11 2015-07-10 Novartis Ag
WO2011051853A1 (en) 2009-10-29 2011-05-05 CarboDesign LLC Manufacturing process for preparing enaniomerically pure 8- aryloctanoic acid derivatives such as aliskiren
EP2523934A1 (en) * 2010-02-10 2012-11-21 Ratiopharm GmbH Salts of aliskiren
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren
CN111423325A (zh) * 2020-04-26 2020-07-17 江苏凯迪恩医药科技有限公司 基于蒽醌类药物的双醋瑞因合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570108A (en) * 1982-07-06 1986-02-11 Stroede Aake Protection device for electrical incandescent lamps
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
CA2121898A1 (en) * 1994-04-21 1995-10-22 Stephen Hanessian Synthesis of prototypes for renin inhibitors
IT1292426B1 (it) * 1997-06-27 1999-02-08 Nicox Sa Sali nitrati di ace-inibitori
JP2005231999A (ja) * 2000-03-08 2005-09-02 Banyu Pharmaceut Co Ltd カルバペネム誘導体の製造方法
DE60138099D1 (de) 2000-07-05 2009-05-07 Speedel Pharma Ag Verfahren zur herstellung von substituierten octanoyl-amiden
US8168616B1 (en) * 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
EP1215201B1 (en) * 2000-12-14 2006-10-18 Speedel Pharma AG Process for the preparation of aryloctanoyl amides
GB0419361D0 (en) * 2004-08-31 2004-10-06 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
KR20080014011A (ko) 2008-02-13
CN101193860B (zh) 2013-01-02
US7767831B2 (en) 2010-08-03
US20080207921A1 (en) 2008-08-28
EP1896411A2 (en) 2008-03-12
JP2013028607A (ja) 2013-02-07
RU2418785C2 (ru) 2011-05-20
CA2608575A1 (en) 2006-12-14
MA29563B1 (fr) 2008-06-02
NZ591010A (en) 2012-06-29
EP2080754A2 (en) 2009-07-22
MX2007015418A (es) 2008-02-21
JP2008542415A (ja) 2008-11-27
TW200716544A (en) 2007-05-01
AR054374A1 (es) 2007-06-20
GT200600208A (es) 2007-03-28
AU2006256938B2 (en) 2009-12-17
BRPI0611919A2 (pt) 2010-10-05
IL187004A0 (en) 2008-02-09
EP2080754A3 (en) 2010-06-02
AU2006256938A1 (en) 2006-12-14
RU2007148226A (ru) 2009-07-20
NZ562889A (en) 2011-11-25
WO2006131304A3 (en) 2007-07-19
WO2006131304A2 (en) 2006-12-14
GB0511686D0 (en) 2005-07-13
ECSP077986A (es) 2008-01-23
TNSN07465A1 (en) 2009-03-17
PE20091359A1 (es) 2009-10-13
ZA200709076B (en) 2008-10-29
SG155209A1 (en) 2009-09-30
NO20080080L (no) 2008-01-04
CN101193860A (zh) 2008-06-04
US20100274027A1 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
PE20070075A1 (es) Procedimiento de preparacion para compuestos inhibidores de renina
CO6450621A2 (es) Sulfonamidas nematocidas
CO6140053A2 (es) Proceso para fabricar 2-amino-5-halobenzamidas 3-sustituidas
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
CY1119039T1 (el) Mykhtoktonikh συνθεση και μεθοδος για ελεγχο επιβλαβων μυκητων
UY28877A1 (es) Compuestos de metil-aril o heteroaril-amida sustituida y composiciones
BRPI0716208A2 (pt) Sistemas e métodos desinfetantes
TW200630482A (en) Aqueous based residue removers comprising fluoride
MX2008010481A (es) Compuestos que tienen afinado para el receptor f-ht6.
PH12014500760A1 (en) Mesoionic pesticides
PE20070724A1 (es) Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas
PE20050948A1 (es) Compuestos de carbamoil-amina como inhibidores de la dipeptidil peptidasa iv
PE20061490A1 (es) Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1
NO20080289L (no) Smoresammensetninger for hydrokarbonblandinger og produkter oppnadd derav
BRPI0702269A (pt) alcanolamidas e uso do mesmo como aditivos de combustìvel
TW200715074A (en) Aqueous cleaning composition and method for using same
ATE529181T1 (de) Neuartiges dispersionsmittel und zusammensetzungen daraus
PE20080835A1 (es) Derivados novedosos de aminopiridina que tienen accion inhibidora selectiva sobre aurora a
TW200734309A (en) Water-soluble benzoazepine compound and its pharmaceutical composition
NI200700189A (es) Ciclopropil -(2,3-dimetilbencil)amidos del ácido 7-{4-[2-(2,6-dicloro-4-metilfenoxi)- etoxi]fenil}-3,9- diazabiciclo [3.3.1]non-6-en-6-carboxílico como inhibidores de renina para el tratamiento de la hipertensión.
TW200942602A (en) Polishing composition
MX2009008028A (es) Agentes antiparasitarios.
NO20083560L (no) Stabiliserte, ikke-vandige rensesammensetninger for mikroelektronikksubstrater
TW200627095A (en) Remover composition
WO2008132966A1 (ja) 化合物、酸発生剤、レジスト組成物およびレジストパターン形成方法

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载